Cormorant Asset Management’s BlossomHill Therapeutics BLSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$67.4M Buy
+3,614,034
New +$71.8M 4.52% 7

Other funds holding BLSM

Cormorant Asset Management's BLSM Position: Q3 2026 in Review

Cormorant Asset Management opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 3,614,034 shares worth $67.4M. The stake represents 4.52% of the portfolio and ranks #7 among its holdings.

39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.

  • Cormorant Asset Management held 3,614,034 shares of BlossomHill Therapeutics worth $67.4M as of Q3 2026.
  • BlossomHill Therapeutics was a new Cormorant Asset Management position in Q3 2026.
  • BlossomHill Therapeutics made up 4.52% of Cormorant Asset Management's portfolio in Q3 2026, its #7 holding.
  • 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.

Based on Cormorant Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.